Key Highlights

• Amendment No. 13 to the Ares Capital JB Funding Loan and Servicing Agreement: Ares Capital Corporation (ARCC) has executed a material amendment to its existing loan and servicing agreement, significantly increasing the maximum facility amount from \$1,300,000,000 to \$1,600,000,000.
• Improved Financing Terms: The applicable spread for rate-based borrowing has been reduced from 1.80% to 1.75% per annum for Benchmark or One Day Advance Benchmark-based borrowings, and from 0.80% to 0.75% per annum for Base Rate borrowings.
• No Make-Whole Premium: The amendment specifies a 0% make-whole premium for lenders becoming party to the agreement after the Thirteenth Amendment effective date.
• Parties to the Agreement: The amendment is executed among Ares Capital JB Funding LLC (Borrower), Ares Capital Corporation (as both Servicer and Transferor), Sumitomo Mitsui Banking Corporation (as Administrative Agent, Lender, and Collateral Agent), Citizens Bank, N.A. (Lender), and Sumitomo Mitsui Trust Bank, Limited, New York Branch (Lender).
• Continued Regulatory and Covenant Compliance: Borrowings under the amended facility remain subject to the various covenants of the loan and the leverage restrictions contained in the Investment Company Act of 1940, as amended.

Detailed Analysis

On February 25, 2026, Ares Capital Corporation (NASDAQ: ARCC) announced a significant amendment to its revolving credit facility (the “SMBC Funding Facility”) with Sumitomo Mitsui Banking Corporation (“SMBC”) and other lenders. This is the Thirteenth Amendment to the Loan and Servicing Agreement originally dated January 20, 2012.

1. Substantial Increase in Credit Capacity

The maximum commitment under the facility has been increased by \$300 million, rising from \$1.3 billion to \$1.6 billion. This expanded capacity enhances ARCC’s financial flexibility, allowing it to fund more transactions, manage liquidity, and potentially capitalize on market opportunities. Such an increase can signal management’s confidence in future deal flow and portfolio growth, which may be interpreted positively by investors.

2. Lower Borrowing Costs

The amendment reduces the applicable interest spreads:

• For Benchmark and One Day Advance Benchmark-based borrowings, the spread drops from 1.80% to 1.75% per annum.
• For Base Rate borrowings, the spread decreases from 0.80% to 0.75% per annum.

These improved terms will lower ARCC’s cost of capital, which, over time, can enhance net investment income and support dividend sustainability or increases, directly affecting shareholder value.

3. Zero Make-Whole Premium for New Lenders

The amendment sets the make-whole premium at 0% for any new lenders joining after the Thirteenth Amendment effective date. This provision may encourage additional lenders to join in the future, further diversifying ARCC’s funding sources and reducing refinancing risk.

4. Parties and Execution

The agreement is executed by senior representatives of each party, including Scott Lem, Chief Financial Officer and Treasurer of Ares Capital Corporation, and senior officers from SMBC, Citizens Bank, and Sumitomo Mitsui Trust Bank. The continued participation of these established lenders underscores the institutional confidence in ARCC’s creditworthiness.

5. Ongoing Compliance

ARCC emphasizes that all borrowings under the facility will remain subject to the restrictive covenants of the agreement and the leverage limits imposed by the Investment Company Act of 1940. This ensures that while ARCC increases its borrowing capacity, it continues to operate within prudent risk management and regulatory frameworks.

Potential Shareholder Impact

• Growth Signal: The substantial increase in borrowing capacity and improved terms may reflect anticipated growth in the portfolio. This could be viewed as an upside catalyst for the stock.
• Lower Financing Costs: Reduced spreads improve the company’s cost structure, potentially increasing earnings available for distribution to shareholders.
• Risk Considerations: While increased leverage can enhance returns, it also raises risk if not managed prudently. However, regulatory and covenant compliance mitigate some of these risks.
• No Immediate Dilution or Share Issuance: The amendment relates to debt capacity, not equity, so there is no dilution from new shares.

Other Noteworthy Details

• Filing Details: The Form 8-K was filed on February 27, 2026, with the SEC, signaling full transparency to the market and compliance with regulatory disclosure obligations.
• Trading Information: ARCC’s common stock is listed on the NASDAQ Global Select Market under the ticker symbol “ARCC.”
• No Soliciting or Tender Offer Communications: The filing does not include any written communications under Rule 425, soliciting material under Rule 14a-12, or pre-commencement tender offer communications under Rule 14d-2(b) or Rule 13e-4(c).
• Not an Emerging Growth Company: The company is not classified as an emerging growth company under current SEC definitions.

Conclusion

This amendment is a noteworthy event for Ares Capital Corporation shareholders. The increased size and improved terms of the SMBC Funding Facility provide ARCC with enhanced flexibility to pursue growth opportunities and manage its balance sheet efficiently, while the lower interest spreads are expected to support future earnings. Investors should monitor the company’s usage of this expanded facility and any changes in leverage over time.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the official SEC filing and consult their financial advisor before making investment decisions. The author does not hold any position in ARCC at the time of publication and makes no warranty as to the accuracy or completeness of the information presented.

View ARES CAPITAL CORP Historical chart here